GlassScriptPhysician profile
Andrea Mariss Tomassoni
NPI 1104896042
$1,327.21
in general payments reported to CMS, 2019-2025
35 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $39.41 · 2021: $161 · 2022: $292 · 2023: $158 · 2024: $307 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.21 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $201.49 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $135.84 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Novo Nordisk INC | $70.65 | 2021-2024 | Wegovy |
| Sumitomo Pharma America, INC. | $65.65 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $64.61 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $63.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.71 | 2025 | |
| Daiichi Sankyo INC. | $48.01 | 2019-2022 | |
| Exeltis, USA INC. | $47.48 | 2022-2023 | Slynd |
| Janssen Pharmaceuticals, INC | $43.33 | 2019-2022 | |
| Organon LLC | $39.59 | 2021-2022 | |
| Olympus America INC. | $38.16 | 2019 | |
| Pfizer INC. | $35.95 | 2021-2025 | |
| Millicent US INC | $33.55 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Lilly USA, LLC | $33.26 | 2022-2023 | Jardiance |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.93 | 2021-2025 | Xifaxan |
| Allergan, INC. | $27.95 | 2019-2020 | |
| Smith+Nephew, INC. | $27.10 | 2019-2025 | Pico 7, Pico 14 |
| Sage Therapeutics, LLC | $26.50 | 2024 | |
| Avion Pharmaceuticals | $25.69 | 2019 | |
| Tolmar, INC. | $19.28 | 2025 | Jatenzo |
| Takeda Pharmaceuticals U.S.A., INC. | $18.15 | 2024 | Trintellix |
| Exact Sciences Corporation | $17.30 | 2023 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $15.03 | 2024 | Nexletol |
| Nestle Healthcare Nutrition INC. | $15.03 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $14.57 | 2019 | |
| Aimmune Therapeutics, INC. | $13.69 | 2024 | |
| Meditrina | $13.47 | 2025 | |
| Dexcom, INC. | $13.21 | 2021 | |
| Hologic Sales and Service, LLC | $13.05 | 2023 | Omni Hysteroscope |
| Myovant Sciences INC. | $12.71 | 2021 | |
| Corcept Therapeutics | $12.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.17 | 2020 | |
| Lupin INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Tomassoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.